Echo Therapeutics (ECTE) Inactive 10-K2013 FY Annual report

Filed: 18 Mar 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abide, assignment, Australia, AzoneTM, bear, Becton, binding, call, Cautionary, chain, channel, charter, choose, compliant, concurrent, currency, default, dermatologic, Dickinson, discourage, Doman, double, drawn, feel, Glysure, IIb, implied, imposition, indemnify, Indemnity, infusion, intercompany, invention, ISO, landlord, lender, lending, mandatory, Maquet, MAZ, MDD, Menarini, methotrexate, middle, minimizing, MLV, NOL, Notified, occasion, outpatient, physical, Pledged, poor, preapproval, premarket, prepay, prepayment, qualitative, ready, repayment, resell, revaluation, Robert, spent, stable, strive, Switzerland, thereunder, transfer, travel, unavailable, undergo, underwritten, uninsured, unwilling, warm, wired, wirelessly, Zealand

Removed: capability, ChoiceTel, comfortable, copier, core, field, hereunder, leader, machinery, media, nonvested, package, prescription, recommendation, redeemed, secret, skincare, tCGM, thousand, voted

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ECTE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements (Nos. 333-164510, 333-152138, 333-92414, 333-101517, 333-106201, 333-122893, 333-134674, 333-143145 and 333-146607) on Form S-8 and Registration Statement (No. 333-175938) on Form S-3 of our report dated March 18, 2013, relating to our audit of the consolidated financial statements of Echo Therapeutics, Inc. (the “Registrant”), appearing in the Annual Report on Form 10-K of the Registrant for the year ended December 31, 2012.

/s/ Wolf & Company, P.C.

Boston, Massachusetts

March 18, 2013